Hypoxic Pulmonary Vasoconstriction Pilot Study

Summary

Hypoxic Pulmonary Vasoconstriction Pilot Study is a clinical trial^[1].

Key Facts

• Hypoxic Pulmonary Vasoconstriction Pilot Study is in the country of United States^[2].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's instance of is recorded as clinical trial^[3].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's start time is recorded as +2011-06-29T00:00:00Z^[4].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's end time is recorded as +2014-01-13T00:00:00Z^[5].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's sponsor is recorded as Eric A. Hoffman^[6].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's main subject is recorded as emphysema^[7].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's main subject is recorded as pulmonary emphysema^[8].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's number of participants is recorded as {'unit': '1', 'amount': '+22'}^[9].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's title is recorded as Pilot Study for Perfusion Heterogeneity: a Mechanistic Image-Based Emphysema Phenotype^[10].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+30'}^[11].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's ClinicalTrials.gov ID is recorded as NCT03733470^[12].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[13].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's research intervention is recorded as sildenafil citrate^[14].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's clinical trial phase is recorded as phase IV clinical trial^[15].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's research site is recorded as University of Iowa Health Care^[16].
• Hypoxic Pulmonary Vasoconstriction Pilot Study's study type is recorded as interventional study^[17].